MultiHance^® 9 Image Library 9 Seidl et al. 58F with melanoma and brain metastases

MultiHance^® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist^® (gadobutrol)¹

The MERIT Study
Seidl et al.
58-year-old woman with melanoma and brain metastases

These are representative images from reference studies; individual results may vary.
Reference: 1. Seidl Z, Vymazal J, Mechi M, et al. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study). AJNR Am J Neuroradiol. 2012 Jun-Jul;33(6):1050-1058.